Naoki Terakawa Selected Research

Naoki Terakawa Research Topics

Disease

27	Endometriosis 01/2021 - 01/2002
16	Ovarian Neoplasms (Ovarian Cancer) 01/2014 - 02/2002
11	Carcinoma (Carcinomatosis) 06/2013 - 01/2002
10	Neoplasms (Cancer) 10/2008 - 05/2002
6	Adenocarcinoma 12/2010 - 07/2002
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2010 - 12/2003
5	Endometrial Neoplasms (Endometrial Cancer) 07/2007 - 05/2002
4	Pain (Aches) 01/2021 - 03/2009
4	Cysts 06/2013 - 01/2002
3	Ovarian Epithelial Carcinoma 07/2011 - 08/2003
3	Infections 10/2007 - 02/2002
3	Infertility (Sterility) 04/2005 - 01/2002
2	Menorrhagia 01/2021 - 01/2021
2	Metrorrhagia (Spotting) 01/2021 - 01/2021
2	Pelvic Pain 01/2021 - 01/2021
2	Dysmenorrhea (Menstrual Pain) 05/2011 - 11/2008
2	Inflammation (Inflammations) 01/2010 - 10/2007
2	Leiomyoma (Uterine Fibroids) 12/2009 - 03/2006
2	Premature Obstetric Labor (Premature Labor) 10/2007 - 02/2005
1	Menstruation Disturbances 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2010
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 03/2009
1	Ovarian Cysts (Ovarian Cyst) 10/2008
1	Stomach Neoplasms (Stomach Cancer) 01/2008
1	Cephalopelvic Disproportion 10/2007
1	Breech Presentation 10/2007
1	Hyperplasia 07/2007

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 06/2013 - 01/2002
5	PlatinumIBA 07/2012 - 01/2002
5	Cisplatin (Platino)FDA LinkGeneric 07/2012 - 01/2002
5	Paclitaxel (Taxol)FDA LinkGeneric 03/2009 - 08/2002
5	Interleukin-6 (Interleukin 6)IBA 04/2005 - 01/2002
4	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2021 - 02/2003
4	Docetaxel (Taxotere)FDA Link 12/2010 - 08/2003
4	Carboplatin (JM8)FDA LinkGeneric 12/2010 - 06/2006
4	Messenger RNA (mRNA)IBA 02/2008 - 01/2002
3	Estrogens (Estrogen)FDA Link 01/2013 - 04/2005
3	NF-kappa B (NF-kB)IBA 01/2012 - 05/2005
3	Aromatase (CYP19)IBA 01/2011 - 01/2008
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2009 - 01/2002
3	Interleukin-8 (Interleukin 8)IBA 10/2008 - 02/2003
3	InterleukinsIBA 10/2008 - 08/2003
2	relugolixIBA 01/2021 - 01/2021
2	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 01/2021 - 01/2021
2	Leuprolide (Lupron)FDA LinkGeneric 01/2021 - 01/2021
2	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 07/2012 - 12/2007
2	Phosphatidylinositols (Phosphatidylinositol)IBA 07/2012 - 12/2007
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2012 - 12/2007
2	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 07/2012 - 12/2007
2	CytokinesIBA 01/2012 - 01/2002
2	Antineoplastic Agents (Antineoplastics)IBA 07/2011 - 06/2002
2	Oral ContraceptivesIBA 05/2011 - 11/2008
2	Analgesics (Analgesic Drugs)IBA 05/2011 - 11/2008
2	dienogest FDA Link 12/2009 - 03/2009
2	RetinoidsIBA 12/2008 - 02/2008
2	taxaneIBA 04/2008 - 08/2003
2	keratinocyte growth factor receptorIBA 02/2008 - 02/2003
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 06/2013
1	Myristic Acid (Tetradecanoic Acid)IBA 07/2012
1	Acetates (Acetic Acid Esters)FDA Link 07/2012
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2012
1	phorbolIBA 07/2012
1	Steroid Receptors (Steroid Receptor)IBA 01/2012
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 09/2011
1	CyclinsIBA 09/2011
1	Etoposide (VP 16)FDA LinkGeneric 07/2011
1	Sirolimus (Rapamycin)FDA Link 07/2011
1	Norethindrone (Norethisterone)FDA LinkGeneric 05/2011
1	Ethinyl Estradiol (Estinyl)FDA LinkGeneric 05/2011
1	CytosineIBA 01/2011
1	GuanineIBA 01/2011
1	Phosphates (Orthophosphate)IBA 01/2011
1	LipopolysaccharidesIBA 01/2010
1	Dinoprostone (PGE2)FDA Link 01/2010
1	SurvivinIBA 12/2009
1	Interleukin-10 (Interleukin 10)IBA 05/2009
1	Buserelin (Suprefact)IBA 03/2009
1	Fluorouracil (Carac)FDA LinkGeneric 03/2009
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2009
1	ThioredoxinsIBA 12/2008
1	CalciumIBA 12/2008
1	Carrier Proteins (Binding Protein)IBA 12/2008
1	LigandsIBA 02/2008
1	PPAR gammaIBA 02/2008
1	Fibroblast Growth Factor 10IBA 02/2008
1	AndrogensIBA 01/2008
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2008
1	p38 Mitogen-Activated Protein KinasesIBA 10/2007

Therapy/Procedure

15	Drug Therapy (Chemotherapy) 09/2011 - 01/2002
6	Therapeutics 10/2008 - 02/2002
5	Cystectomy 01/2014 - 02/2003
4	Hysterectomy 12/2009 - 06/2004
3	Lymph Node Excision (Lymph Node Dissection) 05/2006 - 06/2004
2	Combination Drug Therapy (Combination Chemotherapy) 12/2010 - 03/2009
1	Oral Administration 01/2021
1	Lasers (Laser) 06/2013
1	Aftercare (After-Treatment) 05/2011
1	Neoadjuvant Therapy 12/2010
1	Laparotomy 10/2008
1	Cesarean Section (Caesarean Section) 10/2007